Similarly, miR-210 has shown potential for influencing long-term inflammation and recovery processes, which is consistent with sustained inflammatory pathways like IL-17 and hepatic fibrosis signaling observed in IPA. This evidence concerns the gene IL17A and Ito hypomelanosis.